{
  "id": 5470,
  "text": "Int J Radiat Oncol Biol Phys 2006;65:1170- 1176.Available at: http://www.ncbi.nlm.nih.gov/pubmed/16730136.288.Small W, Mell LK, Anderson P, et al.Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Int J Radiat Oncol Biol Phys 2006;65:1170- 1176.Available at: http://www.ncbi.nlm.nih.gov/pubmed/16730136.288.Small W, Mell LK, Anderson P, et al.Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "术后宫颈癌患者在接受强度调控盆腔放疗时，临床靶区的确定是一个重要的步骤，需要考虑多个因素。通常情况下，临床靶区的界定会结合影像学资料、术后病理报告以及肿瘤的分期等信息。首先，需要确认手术后残余肿瘤的区域以及可能的微转移区域，这是靶区确定的基础。其次，应考虑到盆腔淋巴结的分布情况，以防止肿瘤的淋巴结转移。最后，根据患者的具体情况，如是否存在术后并发症，以及患者的身体状态，适当调整临床靶区的范围和剂量。通过这些步骤，能够更精确地制定放疗计划，提高治疗效果并减少副作用。",
  "query": "根据当前规范化操作，如何确定术后宫颈癌患者接受强度调控盆腔放疗时的临床靶区？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据当前规范化操作，如何确定术后宫颈癌患者接受强度调控盆腔放疗时的临床靶区？\n\n<reference text>: Int J Radiat Oncol Biol Phys 2006;65:1170- 1176.Available at: http://www.ncbi.nlm.nih.gov/pubmed/16730136.288.Small W, Mell LK, Anderson P, et al.Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "术后宫颈癌患者在接受强度调控盆腔放疗时，临床靶区的确定是一个重要的步骤，需要考虑多个因素。通常情况下，临床靶区的界定会结合影像学资料、术后病理报告以及肿瘤的分期等信息。首先，需要确认手术后残余肿瘤的区域以及可能的微转移区域，这是靶区确定的基础。其次，应考虑到盆腔淋巴结的分布情况，以防止肿瘤的淋巴结转移。最后，根据患者的具体情况，如是否存在术后并发症，以及患者的身体状态，适当调整临床靶区的范围和剂量。通过这些步骤，能够更精确地制定放疗计划，提高治疗效果并减少副作用。"
}